A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia
Clinical trial NCT04522375 · WITHDRAWN
Trial details
- NCT number
- NCT04522375
- Sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-30
- Primary completion
- 2025-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.